Cells respond to stress by controlling gene expression at several levels, with little known about the role of translation. Here, we demonstrate a coordinated translational stress response system involving stress-specific reprogramming of tRNA wobble modifications that leads to selective translation of codon-biased mRNAs representing different classes of critical response proteins. In budding yeast exposed to four oxidants and five alkylating agents, tRNA modification patterns accurately distinguished among chemically similar stressors, with 14 modified ribonucleosides forming the basis for a data-driven model that predicts toxicant chemistry with >80% sensitivity and specificity. tRNA modification subpatterns also distinguish SN1 from SN2 alkylating agents, with SN2-induced increases in m(3)C in tRNA mechanistically linked to selective translation of threonine-rich membrane proteins from genes enriched with ACC and ACT degenerate codons for threonine. These results establish tRNA modifications as predictive biomarkers of exposure and illustrate a novel regulatory mechanism for translational control of cell stress response.
Cells respond to stress by controlling gene expression at several levels, with little known about the role of translation. Here, we demonstrate a coordinated translational stress response system involving stress-specific reprogramming of tRNA wobble modifications that leads to selective translation of codon-biased mRNAs representing different classes of critical response proteins. In budding yeast exposed to four oxidants and five alkylating agents, tRNA modification patterns accurately distinguished among chemically similar stressors, with 14 modified ribonucleosides forming the basis for a data-driven model that predicts toxicant chemistry with >80% sensitivity and specificity. tRNA modification subpatterns also distinguish SN1 from SN2 alkylating agents, with SN2-induced increases in m(3)C in tRNA mechanistically linked to selective translation of threonine-rich membrane proteins from genes enriched with ACC and ACT degenerate codons for threonine. These results establish tRNA modifications as predictive biomarkers of exposure and illustrate a novel regulatory mechanism for translational control of cell stress response.
Cells respond to environmental
stressors and xenobiotic exposures
by controlling gene expression with multilayered, complex regulatory
networks. The emergence of tools to quantify the molecular changes
associated with these networks has led to an appreciation for the
mechanistic insights and predictive power derived from transcriptional
profiling, proteomics, and metabolomics.[1−5] Using a novel bioanalytical platform, we recently described an example
of another network that regulates the cellular response to xenobiotic
exposures and other stresses: stress-induced reprogramming of a system
of two-dozen post-transcriptional modifications on tRNA (tRNA), which
promotes selective translation of codon-biased mRNAs for critical
response proteins.[6−8] Most forms of RNA contain modified ribonucleosides,
with more than 120 different chemical structures across all organisms
and 2–3 dozen in any one organism.[9,10] tRNA
is the most extensively modified RNA species, with the presence of
specific ribonucleoside structures affecting the rate and fidelity
of translation,[11,12] tRNA stability,[13,14] cellular stress responses,[6,15,16] and cell growth.[17] To define a systems-level
behavior for tRNA modifications, we developed a chromatography-coupled
tandem quadrupole mass spectrometry (LC-MS/MS) method to quantify
stress-induced changes in the system of modified ribonucleosides in
a population of cellular tRNA molecules or in individual, purified
tRNA species.[7,8,18−20] We applied this approach to budding yeast exposed
to four mechanistically different toxicants (hydrogen peroxide, H2O2; methylmethanesulfonate, MMS; sodium arsenite
NaAsO3; and sodium hypochlorite, NaOCl) and observed agent-specific
changes in the relative quantities of 23 modified ribonucleosides
in tRNA.[7] These results pointed to the
spectrum of modified ribonucleosides in tRNA as a predictive biomarker
of exposure. Furthermore, stress-specific reprogramming of tRNA wobble
modifications was found to result in selective translation of mRNAs
containing biased use of the codons corresponding to these tRNAs,
with the mRNAs representing critical stress response proteins.[6−8]These observations were made with four chemically distinct
toxicants,
which raised questions about the specificity of the tRNA reprogramming
signatures for classes of chemical toxicants (e.g., all oxidants)
and the generality of the translational response mechanism. To test
the hypothesis that cells respond to mechanistically similar toxicants
with similar patterns of tRNA modification reprogramming and that
the patterns are predictive of the chemical class of the toxicant,
we analyzed changes in the levels of 23 modified ribonucleosides in
tRNA from Saccharomyces cerevisiae exposed
to four oxidizing agents (hydrogen peroxide (H2O2), t-butyl hydroperoxide (TBHP), γ-radiation
(γ-rad), and peroxynitrite (ONOO–)) and five
alkylating agents (methylmethanesulfonate (MMS), ethylmethanesulfonate
(EMS), isopropyl methanesulfonate (IMS), N-methyl-N′-nitro-N-nitrosoguanidine (MNNG),
and N-nitro-N-methylurea (NMU)).
Multivariate statistical analysis and data-driven modeling of the
RNA modification patterns proved to be highly predictive of toxicant
chemistry, with bioinformatic and proteomic analyses establishing
a mechanistic link among exposure, tRNA modifications, and codon-biased
translation of response proteins. The results support a 30 year old
model for one of the mechanisms by which SN2 alkylating
agents promote cell death, by damaging membrane proteins, and establish
a novel regulatory mechanism linking exposure to translational response
in cells, which is summarized in Figure 1.
Figure 1
Proposed
model for stress-specific reprogramming of tRNA modifications
leading to selective translation of codon-biased response proteins.
The specific model shown here is based on exposure to the SN2 alkylating agent, methylmethanesulfonate (MMS), which leads to
upregulation of the modified ribonucleoside m3C in tRNA
species coding for threonine and serine, with their cognate codons
enriched (ACC, ACT) in membrane-associated proteins. This model is
consistent with broad mechanisms for MMS-induced toxicity proposed
by Smith and Grisham.[50]
Proposed
model for stress-specific reprogramming of tRNA modifications
leading to selective translation of codon-biased response proteins.
The specific model shown here is based on exposure to the SN2 alkylating agent, methylmethanesulfonate (MMS), which leads to
upregulation of the modified ribonucleoside m3C in tRNA
species coding for threonine and serine, with their cognate codons
enriched (ACC, ACT) in membrane-associated proteins. This model is
consistent with broad mechanisms for MMS-induced toxicity proposed
by Smith and Grisham.[50]
Experimental Procedures
Materials
All chemicals and reagents were of the highest
purity available and were used without further purification. MMS,
EMS, NMU, TBHP, H2O2, RNase A, and alkaline
phosphatase were obtained from Sigma Chemical Co. (St. Louis, MO).
IMS was obtained from Pfaltz & Bauer, Inc. (Waterbury, CT). MNNG
was obtained from TCI America (Portland, OR). Sodium peroxynitrite
was obtained from Cayman Chemical Co. (Ann Arbor, MI). Nuclease P1
was obtained from Roche Diagnostic Corp. (Indianapolis, IN). Phosphodiesterase
I was obtained from USB (Cleveland, OH). Yeast extract and peptone
were obtained from Biomed Diagnostics, Inc. (White City, OR). Micron
YM10 filters were obtained from PALL Corp. (Port Washington, NY).
HPLC-grade water and acetonitrile were obtained from Mallinckrodt
Baker (Phillipsburg, NJ). S. cerevisiae BY4741 was obtained from American Type Culture Collections (Manassas,
VA).
S. cerevisiae Cytotoxicity Dose–Response
Assays
S. cerevisiae BY4741
was cultured in YPD (yeast extract-peptone-dextrose) media with 200
μg/mL of geneticine at 30 °C with shaking at 220 rpm. Each
culture was grown to mid log phase (OD660 ∼ 0.6–0.8)
followed by exposure to the following toxicants and concentrations:
H2O2 (0, 2, 3.5, 5, 10, 15, and 20 mM), TBHP
(0, 0.7, 2, 4, 7, 14, 22, 25, and 29 mM), ONOO– (0,
0.3, 0.5, 0.8, 1.0, 1.5, and 2.0 mM), γ-rad (116 Gy/min) (0,
21.3, 168, 327, 513, and 606 Gy), MMS (0, 1.2, 6, 12, 24, 36, and
48 mM), EMS (0, 0.19, 0.29, 0.39, 0.49, and 0.58 M), IMS (0, 8, 17,
33, 50, and 66 mM), MNNG (0, 41, 61, 82, 102, and 136 mM), and NMU
(0, 1.3, 2.3, 3.2, and 4.2 mM). After 1 h at 30 °C, these cultures
were diluted 104-fold with YPD medium, and 50 μL
was plated on YPD agar. Survival rates of exposed cells were determined
by comparing colony counts for untreated and treated samples after
2 days of growth.
Cell Exposure and tRNA Isolation
Cultures of S. cerevisiae at mid log
phase (OD660 ∼
0.6; ∼2 × 107 cells) were treated with 5 mM
H2O2, 25 mM TBHP, 0.8 mM ONOO–, 500 Gy γ-rad (116 Gy/min), 24 mM MMS, 190 mM EMS, 50 mM IMS,
82 mM MNNG, or 3.2 mM NMU and incubated for 1 h at 30 °C alongside
untreated control cultures. Cells were pelleted by centrifugation
and resuspended in TRIzol reagent with the addition of antioxidants
(0.1 mM desferrioxamine and 0.1 mM butylated hydroxytoluene) and deaminase
inhibitors (5 μg/mL coformycin and 50 μg/mL tetrahydrouridine).
Cells in this solution were lysed by three cycles of bead beating
in a Thermo FP120 bead beater at 6.5 m/s for 20 s each cycle, with
1 min of cooling on ice between cycles. The lysates was mixed with
one-volume of chloroform, and phases were separated by centrifugation.
Small RNA in the aqueous phase was isolated using using the PureLink
miRNA isolation kit according to manufacturer’s instructions.
Each sample yielded ∼6 μg of RNA composed of ∼90%
tRNA, as judged by Bioanalyzer analysis (Agilent Corporation).
Quantification
of tRNA Modifications
tRNA modifications
were quantified using an established LC-MS/MS method,[7] which starts with hydrolysis of tRNA (6 μg) in a
solution (50 μL; pH 6.8) containing 30 mM sodium acetate, 2
mM ZnCl2, 0.02 unit/μL of nuclease P1, 0.1 unit/μL
of RNase A, 5 μg/mL coformycin, 50 μg/mL tetrahydrouridine,
0.1 mM deferoxamine mesylate, 0.1 mM butylated hydroxytoluene, and
6 pmol of [15N]5-2′-deoxyadenosine
([15N]5-dA) as an internal standard. Following
incubation at 37 °C for 3 h, the solution was augmented (additional
50 μL volume) with an additional 30 mM sodium acetate, 0.2 unit/μL
of alkaline phosphatase, and 0.01 unit/μL of phosphodiesterase
I at a final pH of 7.8 and incubated 37 °C overnight. Proteins
were removed by centrifugal ultrafiltration using a Microcon YM-10
filter. An aliquot of filtrate containing ∼0.4 μg of
ribonucleosides was loaded on a Thermo Scientific Hypersil GOLD aQ
reverse-phase HPLC column (150 × 2.1 mm, 3 μm particle
size), and ribonucleosides were eluted with the following gradient
of acetonitrile in 8 mM ammonium acetate at a flow rate of 0.3 mL/min
at 36 °C: 0–18 min, 0%; 18–23 min, 0–1%;
23–28 min, 1–6%; 28–30 min, 6%; 30–40
min, 6–100%; 40–50 min, 100%. The HPLC column was coupled
to an Agilent 6410 Triple Quadrupole LC/MS mass spectrometer with
an electrospray ionization source operated in positive ion mode with
the following parameters: gas temperature, 350 °C; gas flow,
10 L/min; nebulizer, 20 psi; and capillary voltage, 3500 V. The first
and third quadrupoles (Q1, Q3) were fixed to unit resolution, and
the modifications were quantified by predetermined molecular transitions.
Q1 was set to transmit the parent ribonucleoside ions, and Q3 was
set to monitor the deglycosylated product ions, except for pseudouridine
(Y), which was detected by setting Q1 to transmit the parent ion and
Q3 set to monitor the m/z = 125
product ion resulting from pyrimidine ring fragmentation.[7,21] The dwell time for each ribonucleoside was 200 ms. The retention
time, m/z of the transmitted parent
ion, m/z of the monitored product
ion, fragmentor voltage, and collision energy of each modified nucleoside
and 15N-labeled internal standard are as follows: D, 2.2
min, m/z 247 → 115, 80 V,
5 V; Y, 2.3 min, m/z 245 →
125, 80 V, 10 V; m5C, 5.4 min, m/z 258 → 126, 80 V, 8 V; Cm, 6.4 min, m/z 258 → 112, 80 V, 8 V; m5U,
7.9 min, m/z 259 → 127, 90
V, 7 V; ncm5U, 8.7 min, m/z 302 → 170, 90 V, 7 V; ac4C, 19.0 min, m/z 286 → 154, 80 V, 6 V; m3C, 5.0 min, m/z 258 →
126, 80 V, 8 V; Um, 10.7 min, m/z 259 → 113, 90 V, 7 V; m7G, 8.5 min, m/z 298 → 166, 90 V, 10 V; m1A,
6.9 min, m/z 282 → 150, 100
V, 16 V; mcm5U, 14.6 min, m/z 317 → 185, 90 V, 7 V; m1I, 16.0 min, m/z 283 → 151, 80 V, 10 V; Gm, 17.2 min, m/z 298 → 152, 80 V, 7 V; m1G, 18.8 min, m/z 298 →
166, 90 V, 10 V; m2G, 22.2 min, m/z 298 → 166, 90 V, 10 V; I, 7.8 min, m/z 269 → 137, 80 V, 10 V; mcm5s2U, 31.3 min, m/z 333
→ 201, 90 V, 7 V; [15N]5-dA, 30.0 min, m/z 257 → 141, 90 V, 10 V; m22G, 31.7 min, m/z 312 → 180, 100 V, 8 V; t6A, 32.8 min, m/z 413 → 281, 100 V, 8 V; Am, 33.1
min, m/z 282 → 136, 100 V,
15 V; yW, 34.1 min, m/z 509 →
377, 120 V, 10 V, and i6A, 34.5 min, m/z 336 → 204, 120 V, 17 V. The signal from
each modified nucleoside was normalized by dividing by the signal
from [15N]5-dA for the purpose of comparison
between samples. Complete analysis was performed as technical duplicates
of each of five biological replicates, with samples from each biological
replicate analyzed as a single batch to minimize the influence of
day-to-day variation in instrument performance.
Data Analysis
Exposure-induced changes in the quantities
of modified ribonucleosides were calculated as fold-change values
using the normalized MS signal intensities for the treated and unexposed
samples. This was accomplished by averaging the normalized MS signal
intensity for each ribonucleoside in the three control samples and
then dividing the corresponding normalized MS signal intensity for
each ribonucleoside in each treated sample by this average control
value. These fold-change values are presented in Table S1, and the mean (±standard deviation) fold-change
values for the five replicates are presented in Table S2. The fold-change values were then analyzed by hierarchical
clustering using the centroid linkage algorithm in Cluster 3.0 following
log2 transformation of the fold-change data; heat map representations
were produced using Java Treeview, as described elsewhere.[7] The heat map for the entire data set is shown
in Figure S3, and that for the averaged
data, in Figure 3.
Figure 3
Hierarchical clustering analysis of average fold-change
values
for tRNA modifications in total tRNA from cells exposed to equitoxic
(LD80) doses of different alkylating agents and oxidizing
agents. On the basis of the dose–response curves shown in Figure S1, budding yeast cells were exposed to
LD80 doses of the various agents, and tRNA modifications
were quantified by LC-MS/MS. The fold-change values (Table S2, with significance testing) were derived from the
average of normalized MS signal intensity data from five biological
replicates (Figure S2 and Table S1), and
hierarchical clustering analysis was performed in log space (log2).
Data-Driven Modeling
To assess the predictive power
of the stress-altered tRNA modification patterns, the normalized MS
signal intensities for each biological replicate of treated and control
cells was used to develop a data-driven model (Figure 4A). The data for individual samples were labeled as one of
three classes of toxicant exposure: unexposed control (CT), alkylating
agent-exposed (AA), and oxidizing agent-exposed (OX). A classification
model was then developed using K-nearest neighbor classification.
From each exposure class, normalized ribonucleoside signal intensities
were compared to the other classes using multiple t-tests with Bonferroni correction, and those with p values < 0.01 were assigned as unique features of that exposure
group. All of these unique features were then set as parameters to
construct a data-driven model using the programming software R, in
which all data were randomly assigned into two groups: a training
set to build the model and a testing set to evaluate the prediction
accuracy of the model. For this evaluation, the confusion matrix method
(Figure 4B) was used to determine prediction
sensitivity and prediction specificity.
Figure 4
A data-driven model to define the ability of tRNA modification
spectra to distinguish different stresses. K-nearest neighbor classification
was used to develop a data-driven model (A) for the normalized MS
signal intensities for each biological replicate of treated and control
cells (Table S1; hierarchical clustering
analysis of data sets shown in Figure S3). A confusion matrix (B) shows the number of false positives, false
negatives, true positives, and true negatives that were used to determine
prediction sensitivity (C) and prediction specificity (D) of the model,
based on a total of 20 training and test cycles. A low standard error
(<2%) demonstrates the stability of the data-driven model.
SILAC Proteomics
MMS-induced changes in protein levels
were determined by SILAC proteomics.[8,22] To prepare
isotopically labeled proteins, Lys1Δ yeast
cells were grown in yeastnitrogen base (YNB) liquid medium containing
30 mg/L of l-lysine-U-[13C]6, [15N]2 (Isotec-SIGMA, Miamisburg, OH) for at least
10 generations, until they reached log-phase (OD600 ∼
0.7).[23] Wild-type yeast cells were grown
to log phase (OD600 ∼ 0.7) in YNB medium containing
30 mg/L of l-lysine. Cells were harvested by centrifugation
at 1500g for 10 min at 4 °C and washed twice
with ice-cold water. Cells were then lysed by suspension in alkaline
buffer (2 M NaOH, 8% 2-mercaptoethanol v/v), and proteins were precipitated
by adding 50% TCA and incubating on ice for 10 min, followed by centrifugation
at 15 000g for 15 min at 4 °C. The pellet
was resuspended in lysis buffer (8 M urea, 75 mM NaCl, 50 mM Tris,
pH 8.2, 50 mM NaF, 50 mM β-glycerophosphate, 1 mM sodium orthovanadate,
10 mM sodium pyrophosphate, 1 mM phenylmethylsulfonyl fluoride).[24] Protein concentration was determined by the
Bradford assay.[25] Heavy SILAC-labeled lys1Δ yeast proteins were used as a global internal
standard.[26] For the MMS exposure studies,
cells (OD600 ∼ 0.7) were treated for 1 h with 0.0125%
MMS in YNB media at 30 °C, which caused less than 5% cell death
based on a cytotoxicity assay. Proteins were then harvested as noted
earlier.For the proteomic analyses, internal standard was added
to all treated and untreated protein samples (1:1), and the protein
mixture was subjected to disulfide reduction by incubation for 2.5
h at 37 °C in 1 mM dithiothreitol, followed by thiol alkylation
by 5.5 mM iodoacetamide for 40 min at ambient temperature in the dark.
Proteins were then digested with 50:1 (w/w) trypsin overnight at 37
°C. Peptide mixtures were loaded onto a Vydac C18 trap column
(150 μm × 10 mm; 5 μm diameter, 300 Å pore-size
particle; Grace, Deerfield, IL) at flow rate of 5 μL/min and
eluted onto a Vydac C18 analytical column (75 μm × 150
mm, 5 μm diameter, 300 Å pore-size particle) at 200 nL/min
with a gradient of 2–98% acetonitrile with 0.1% formic acid
over 180 min. Eluted peptides were analyzed by mass spectrometric
analysis on a QSTAR-XL system (Applied Biosystems/MDS Sciex, Foster
City, CA). Data were obtained from three biological replicates. Acquired
MS/MS spectra were parsed by Spectrum Mill (Agilent Technologies,
Foster City, CA) and searched against Saccharomyces Genome Database
(SGD). SILAC peptide and protein quantitation was performed with differential
expression quantitation, and SILAC protein ratios were determined
as the average of all peptide ratios assigned to the protein. Differential
protein expression was determined by Student’s t test between samples.A total of 2381 high-confidence proteins
with a false-discovery
rate of 0.5% were identified in control and MMS-treated samples.[22] To control for protein expression regulated
by transcription, rather than by translational control mechanisms,
the protein expression data were corrected using microarray data from
our previous studies with the same yeast strain and MMS treatment
conditions.[6,27,28] After removing genes that show the same expression change (up, down,
or no change) for both mRNA and protein, we identified 222 upregulated
and 438 downregulated genes whose expression is significantly regulated
by translational machinery (Table S3).
Gene Ontology Annotation
Gene functional categorization
and pathway analysis were performed with DAVID Bioinformatics Resources
2011.[29] The annotated proteins are clustered
according to the biological process branch of the Gene Ontology (GO)
annotation. The statistical significance of over- or under-representation
of proteins in each GO category was assessed using a hypergeometric
distribution, and the significance indicated by the p values for each GO category.[29]
Results
Establishing
Equivalent Stress Conditions for Oxidizing and
Alkylating Agents
A quantitatively meaningful comparative
analysis of stress responses requires that cells experience equivalent
levels of stress. To this end, we chose cytotoxicity as a common end
point, with doses producing 80% lethality for a 1 h exposure to the
four oxidizing agents (ONOO–, H2O2, γ-rad, TBHP) and five alkylating agents (MMS, EMS,
IMS, MMNG, MNU), the structures of which are shown in Figure 2. The dose–response curves for the nine agents
are shown in Figure S1, from which we determined
LD80 doses of 5 mM H2O2, 25 mM TBHP,
0.8 mM ONOO–, 510 G γ-radiation (116 Gy/min),
24 mM MMS, 190 mM EMS, 50 mM IMS, 82 mM MNNG, and 3 mM NMU. To assess
the role of Trm140, which methylates C3 of cytosine at position 32
in several tRNAs (see below), in the cellular response to alkylating
agent exposures, cell survival was determined for wild-type and Δtrm140 mutant S. cerevisiae exposed to the alkylating agents at LD80 doses determined
for wild-type cells. As shown in Figure S3, loss of Trm140 modestly but significantly increased the sensitivity
of the cells to SN2 alkylating agents MMS and EMS but not
the other three SN1 alkylating agents.
Figure 2
Structures of the oxidizing
and alkylating agents used in the studies.
Structures of the oxidizing
and alkylating agents used in the studies.
Quantifying Exposure-Induced Changes in the Full Set of tRNA
Modifications
Having defined equivalent exposure conditions,
the effect of exposure to nine different agents on the relative quantities
of 23 tRNA modifications was determined using LC-MS/MS. The analysis
consisted of five biological replicate sets of samples each comprised
of three unexposed controls and one exposure for each of the nine
agents. Normalized mass spectrometric (MS) signal intensities for
each modification in the three unexposed controls were averaged, and
changes in the MS signal intensities for the exposed samples were
determined relative to this control value. Table
S1 shows the complete set of 1380 data elements for the five
biological replicates of this analysis, with the mean fold-change
for each ribonucleoside and each exposure shown in Table S2. The results reveal that the levels of 22 of the
23 modified ribonucleosides were changed significantly by the various
exposures (p < 0.05 by Student’s t test); only m5U did not change significantly
(Table S2).
Stress Induces Reprogramming
of tRNA Modifications with Unique
Class- and Agent-Specific Patterns
To identify exposure-dependent
patterns in the relative quantities of tRNA modifications in cells
exposed to the nine toxicants, the fold-change data in Tables S1 and S2 were subjected to hierarchical
clustering analysis, with the heat map representations shown in Figures 3 and S3. Analysis of the averaged data sets in Figure 3 shows clear class-specific distinctions for the
groups of oxidizing agents and alkylating agents. All alkylating agents
caused significant (p < 0.05) increases in Um,
m2G, mcm5s2U, mcm5U, and
m1A, but these modifications were not significantly affected
by the oxidizing agents. Furthermore, levels of yW and m1I decreased significantly in all alkylator-exposed cells, but the
changes in oxidant-exposed cells were not significant. In contrast,
the levels of ncm5U, m5C, and i6A
did not change in cells exposed to any of the alkylating agents, but
they increased significantly in response to all oxidizing agents.
In addition to these class-specific signature patterns of modified
ribonucleosides, there were also “sub-signatures” apparent
for both classes of toxicant. This is most apparent for the alkylating
agents, for which SN2 alkylating agents[30] (EMS, MMS) cause increases in m3C and m7G, whereas SN1 alkylating agents[30] (IMS, MNNG, MNU) uniquely increase Am (Figure 3).Hierarchical clustering analysis of average fold-change
values
for tRNA modifications in total tRNA from cells exposed to equitoxic
(LD80) doses of different alkylating agents and oxidizing
agents. On the basis of the dose–response curves shown in Figure S1, budding yeast cells were exposed to
LD80 doses of the various agents, and tRNA modifications
were quantified by LC-MS/MS. The fold-change values (Table S2, with significance testing) were derived from the
average of normalized MS signal intensity data from five biological
replicates (Figure S2 and Table S1), and
hierarchical clustering analysis was performed in log space (log2).
A Data-Driven Model for
Distinguishing Alkylation and Oxidation
Stresses
The class- and agent-specific distinctions revealed
by clustering analysis suggested that the stress-specific patterns
of tRNA modifications could be used to predict exposure chemistry.
To test this hypothesis, we developed a data-driven model (Figure 4A) using the K-nearest
neighbor classification method to classify and predict the agent classes
in term of tRNA modification spectra. Following 20 training and test
cycles of supervised learning, a stable model (standard error <2%)
was established. As shown in the confusion matrix in Figure 4B, which reports the average number of false positives,
false negatives, true positives, and true negatives, the model proved
to have sensitivities of 95% for the alkylating agent-exposed group
(AA), 94% for oxidant exposures (OX), and 78% for unexposed cells
(CT). The predictive specificities are 95% for AA, 76% for OX, and
98% for CT (Figure 4C). On the basis of this
model, a set of 14 modified ribonucleosides was identified as contributing
the most to distinguishing the exposures, with the group for predicting
alkylating agents composed of m3C, m7G, yW,
mcm5U, Am, Gm, m5C, mcm5s2U, and m1I, and those for identifying oxidizing agent-exposures
consisting of m5C, m3C, m7G, Gm,
ncm5U, m22G, i6A, yW,
and Cm (Table 1). These features match those
revealed in the hierarchical clustering analysis (Figure 3).
Table 1
tRNA Modifications
That Contribute
Most Significantly to the Data-Driven Model for Predicting Exposure
Chemistrya
rN1
tRNA
position
modifying enzyme
rN1
tRNA
position
modifying enzyme
Modifications Increased
by Alkylating Agents
Modifications Increased
by Oxidizing Agents
m3C
multiple
32, e2
Trm140
m5C
tRNALeuCAA
34
Trm4
m7G
multiple
46
Trm8, Trm82
tRNAPheGAA
40
Trm4
mcm5U
tRNAArgUCU
34
Trm9, Elp1-6, Kti11-13
multiple
48
Trm4
mcm5s2U
tRNAGluUUC
34
Trm9, Nfs1, Elp1-6, KTI11-13
multiple
49
Trm4
Am
tRNAHisGUG
4
unknown
ncm5U
tRNAValUAC
34
Elp1-6, Kti11-13
Gm
multiple
18
Trm3
m22G
multiple
26
Trm1
tRNAPheGAA
34
Trm7
i6A
multiple
37
Mod5
m2G
multiple
10
Trm11
Cm
multiple
32
Trm7
tRNAValCAC
26
unknown
tRNATrpCCA
34
Trm7
Modifications
Decreased
by Alkylating Agents
multiple
4
unknown
yW
tRNAPheGAA
37
Trm5
m1I
tRNAAlaIGC
37
Tad1, Trm5
The modified ribonucleosides
(rN)
are organized into three groups, depending on whether their levels
increased or decreased in response to the two classes of chemical
stress (alkylating agents; oxidizing agents). Specific tRNAs are noted
if the modification is located in a single tRNA species. Information
was from Modomics Database,[10] Saccharomyces
Genome Database,[43] and D’Silva et
al.[57] The link between m3C and
cell response to SN2 alkylating agents MMS and EMS is shown
in Figure S3, in which it is shown that
loss of Trm140 confers sensitivity these agents.
A data-driven model to define the ability of tRNA modification
spectra to distinguish different stresses. K-nearest neighbor classification
was used to develop a data-driven model (A) for the normalized MS
signal intensities for each biological replicate of treated and control
cells (Table S1; hierarchical clustering
analysis of data sets shown in Figure S3). A confusion matrix (B) shows the number of false positives, false
negatives, true positives, and true negatives that were used to determine
prediction sensitivity (C) and prediction specificity (D) of the model,
based on a total of 20 training and test cycles. A low standard error
(<2%) demonstrates the stability of the data-driven model.The modified ribonucleosides
(rN)
are organized into three groups, depending on whether their levels
increased or decreased in response to the two classes of chemical
stress (alkylating agents; oxidizing agents). Specific tRNAs are noted
if the modification is located in a single tRNA species. Information
was from Modomics Database,[10] Saccharomyces
Genome Database,[43] and D’Silva et
al.[57] The link between m3C and
cell response to SN2 alkylating agents MMS and EMS is shown
in Figure S3, in which it is shown that
loss of Trm140 confers sensitivity these agents.
Linking tRNA Modification Patterns to Selective
Translation:
Analysis of MMS-Induced Changes in the Proteome
The observation
that SN2 alkylating agents caused differential upregulation
of m3C in tRNA is reminiscent of H2O2-induced increases in m5C (Figure 3) that led to selective translation of mRNAs enriched in the Leu
codon TTG.[8] In addition, the increase in
mcm5U following MMS exposure has been linked to Trm9 and
to the selective translation of mRNAs enriched with the Arg codon
AGA.[6,19] Following this line of logic with MMS-treated
cells, m3C is present at position 32 of the anticodon loop
of tRNAThr(IGU), tRNASer(UGA), and tRNASer(CGA) in S. cerevisiae, with
these tRNAs reading codons ACT, TCA and TCG, respectively.[31] Position 32 is adjacent to the anticodon (positions
34–36) and has the potential to modulate codon–anticodon
interactions. It was thus hypothesized that MMS treatment would cause
upregulation of proteins containing high levels of Thr and Ser. To
test this hypothesis, we performed a comparative analysis of MMS-altered
protein expression in S. cerevisiae using SILAC proteomics to quantify soluble proteins.[22] This analysis yielded 2381 high-confidence proteins
with a false-discovery rate of 0.5%.[22] To
control for protein expression regulated by transcription, rather
than by translational control mechanisms, we corrected the protein
expression data using microarray data from our previous studies with
the same yeast strain and MMS treatment conditions.[6,27,28] After removing genes that show the same
expression change (up, down, or no change) for both mRNA and protein,
we identified 222 upregulated and 438 downregulated genes whose expression
is significantly regulated by translational machinery (Table S3). This corrected index of protein expression
was then evaluated for codon usage to test the hypothesis that MMS
alters translational efficiency of genes with biased use of codons
related to m3C. To minimize the possibility that the influence
of m3C is counterbalanced by other functional constraints,
we considered only proteins with high usage of optimal codons (each
being >3% of the total codons in the gene for the protein). Among
the Thr codons regulated by tRNAThr(IGU) (ThrACA, ThrACC, ThrACG, ThrACT) and Ser
codons regulated by tRNASer(UGA) and tRNASer(CGA) (SerTCA, SerTCG), only ThrACC and
ThrACT are optimal codons, which are more efficiently translated
and more frequently used by yeast genome in comparison with other
synonymous codons (ThrACA, ThrACG).[32] As a result, other codons are rarely used, and
their influence is therefore limited. Indeed, less than 20 of 660
MMS-altered proteins identified in this study have significantly high
usage of these nonoptimal codons (hypergeometric distribution, p < 0.01; yeast genome as background). However, as shown
in Figure 5A,B, genes upregulated by MMS treatment
are significantly skewed to higher usage of ThrACC and
ThrACT codons in comparison with downregulated genes (Student’s t test; ThrACC, p = 3.8 ×
10–09; ThrACT, p = 8.0
× 10–7). This is also apparent as a shift in
the distribution of proteins with different ACC and ACT codon content
(Figures 5C,D; Kolmogorov–Smirnov test:
ThrACC, p = 3.7 × 10–06, ThrACT, 1.9 × 10–5). The ThrACC codon is significantly enriched in 13% of upregulated genes
(29 of 222; hypergeometric distribution, p < 0.01,
with yeast genome as background), whereas only 7.5% of downregulated
genes (33 of 438) have high usage of this codon (chi-squared test:
χ2 = 5.29, p = 0.021) (Figure 5E). Similarly, the ThrACT codon is overrepresented
in 9.0% of upregulated genes (20 of 222; hypergeometric distribution, p < 0.01) but only in 4.1% of downregulated genes (18
of 438) (chi-squared test: χ2 = 6.52, p = 0.011) (Figure 5F). Furthermore, if we
consider the summed usage of the four Thr codons and two Ser codons
from tRNAs possessing m3C, then no significant difference
is observed between up- and downregulated genes, indicating the over-representation
of ThrACC and ThrACT codons in upregulated genes
is not due to the overall high usage of Thr and Ser in the proteins.
These results support the idea that the four Thr codons are differentially
recognized by m3C-modified tRNAThr and that
m3C-modified tRNAThr predominantly interacts
with ACU and ACC to enhance translation. An analysis of statistically
significant use of ACC and ACT codons in genes in Gene Ontology categories
reveals highly significant enrichment of translation functions in
genes upregulated by MMS and in intermediary metabolism categories
in genes downregulated by MMS, as shown in Figure
S4.
Figure 5
Proteomic analysis reveals that exposure to the SN2
alkylating agent, MMS, causes selective translation of mRNAs possessing
biased use of the threonine codons ACC and ACT that are decoded by
of tRNAThr(IGU), one of three tRNAs possessing MMS-regulated
m3C at position 34 (Figure 3). SILAC-based
proteomic analysis revealed that MMS treatment induced up- or downregulation
of 694 of 2381 proteins independent of changes in mRNA levels (Table S3). The upper box plots show that the
threonine codons ACC (A) and ACT (B) are used significantly more frequently
in genes for proteins upregulated by MMS exposure than in downregulated
proteins, with significance demonstrated by a Student’s t test (p = 3.8 × 10–9 and p = 8.0 × 10–7, respectively).
Similarly, the distribution plots in middle panels C and D demonstrate
a significant MMS-induced shift in the population of proteins enriched
in codons ACC (C) and ACT (D), with significance demonstrated by a
Kolmogorov–Smirnov test (p = 3.7 × 10–6 and 1.9 × 10–5, respectively).
The lower tables show that the threonine codons ACC (E) and ACT (F)
are significantly enriched in genes upregulated by MMS exposure (29
of 222; hypergeometric distribution, p < 0.01),
whereas the codons are under-represented relative to genome averages
in genes downregulated by MMS (chi-squared test: ACC, χ2 = 5.29, p = 0.021; ACT, χ2 = 6.52, p = 0.011). Figure
S4 shows an analysis of statistically significant use of ACC
and ACT codons in MMS-regulated genes (Table S3) in Gene Ontology categories, and Table S4 lists proteins with threonine content >10%.
Proteomic analysis reveals that exposure to the SN2
alkylating agent, MMS, causes selective translation of mRNAs possessing
biased use of the threonine codons ACC and ACT that are decoded by
of tRNAThr(IGU), one of three tRNAs possessing MMS-regulated
m3C at position 34 (Figure 3). SILAC-based
proteomic analysis revealed that MMS treatment induced up- or downregulation
of 694 of 2381 proteins independent of changes in mRNA levels (Table S3). The upper box plots show that the
threonine codons ACC (A) and ACT (B) are used significantly more frequently
in genes for proteins upregulated by MMS exposure than in downregulated
proteins, with significance demonstrated by a Student’s t test (p = 3.8 × 10–9 and p = 8.0 × 10–7, respectively).
Similarly, the distribution plots in middle panels C and D demonstrate
a significant MMS-induced shift in the population of proteins enriched
in codons ACC (C) and ACT (D), with significance demonstrated by a
Kolmogorov–Smirnov test (p = 3.7 × 10–6 and 1.9 × 10–5, respectively).
The lower tables show that the threonine codons ACC (E) and ACT (F)
are significantly enriched in genes upregulated by MMS exposure (29
of 222; hypergeometric distribution, p < 0.01),
whereas the codons are under-represented relative to genome averages
in genes downregulated by MMS (chi-squared test: ACC, χ2 = 5.29, p = 0.021; ACT, χ2 = 6.52, p = 0.011). Figure
S4 shows an analysis of statistically significant use of ACC
and ACT codons in MMS-regulated genes (Table S3) in Gene Ontology categories, and Table S4 lists proteins with threonine content >10%.
Discussion
We recently discovered a system of translational
control of the
cellular stress response, in which stress-induced reprogramming of
the two-dozen modified ribonucleosides in tRNA causes the selective
translation of codon-biased mRNAs for critical response proteins.[6−8,33] The studies revealed that mechanistically
different chemical stressors produced signature patterns of changes
in the relative quantities of the various tRNA modifications. For
example, H2O2 treatment increased the levels
of Cm, m5C and m22G, whereas HOCl,
NaAsO2 and MMS either did not affect these modifications
or lowered their levels.[7] These results
raised the question of the predictive power of tRNA modification patterns
to identify a specific stressor and to distinguish among chemically
similar stressors. To address these questions, we developed a convergent
platform of bioanalytical and mathematical tools to perform a systems-level
analysis of patterns of change in the tRNA modifications in cells
exposed to four oxidizing agents and five alkylating agents. This
highly precise analysis (12% variance among biological replicates;
see ref (7)) revealed
significant class-specific features that distinguished oxidizing agents
from alkylating agents (Figure 3), with 14
modifications forming the basis for a data-driven model that predicted
toxicant chemistry with >80% sensitivity and specificity (Figure 4). Furthermore, tRNA modification spectra distinguished
SN1 from SN2 alkylating agents, with SN2 agents causing a coordinated increase in m3C and selective
translation of threonine-rich membrane proteins derived from ACT-rich
genes. These results establish tRNA modifications as predictive biomarkers
of exposure and illustrate a novel regulatory mechanism for translational
control of cell stress response.
tRNA Modification Spectra as Biomarkers of
Exposure
The class-specific patterns in the spectrum of tRNA
modifications
revealed by hierarchical clustering analysis (Figure 3) motivated the development of a data-driven model to assess
the predictive power of the system of modified ribonucleosides. Such
a model would provide insights into biological function of the system
and the utility of tRNA modifications as biomarkers of exposure. The
resulting model identified 14 of 25 tRNA modifications in S. cerevisiae as contributing most significantly
to distinguishing the two classes of agents. As discussed shortly,
several of these modified ribonucleosides have been observed to play
roles in the cellular response to H2O2 and MMS
exposures,[6−8] including m5C, mcm5U, and mcm5s2U, which supports the biological relevance of
the model. The predictive power of the model, as revealed by confusion
matrix analysis, was remarkably strong, with overall sensitivity and
specificity over 80%. Examination of the individual specificity and
sensitivity for oxidants and alkylating agents, however, revealed
that the model had greater predictive power for the latter (>95%
sensitivity
and specificity versus 76–78% for oxidants; Figure 4). Although the basis for this difference is unclear,
it is possible that alkylating agents produce a more complicated or
extensive response in terms of activating more gene expression or
requiring a broader set of responses than oxidizing agents for the
same level of cytotoxicity. By any mechanism, it is striking that
changes in the levels of 14 modified ribonucleosides are highly predictive
of exposure chemistry in a manner similar to that with transcriptional
profiling, proteomics, and metabolomics.[34−37] The predictive power of the tRNA
modifications likely lies in their link to the system of biased codon
use in families of stress response genes, for which we have observed
that different stresses uniquely upregulate specific sets of survival
and damage mitigation genes.[6−8,20,22,33] While further
study is needed to compare the predictive power of tRNA modification
patterns relative to other large ‘omic data sets following
exposure to these toxicants, the apparent mechanistic interdependence
of tRNA modifications, selective translation of survival proteins,
and the resulting changes in cell phenotype suggests the potential
for strongly parallel and complementary biomarker signatures.
Assigning
Biological Function to Stress-Predictive Ribonucleosides
While some of the stress-regulated modified ribonucleosides in
Table 1 are located at more than one position
in a tRNA and in multiple tRNA species, which complicates interpretation
of their biological function, 10 of them are found in the anticodon
loop, which suggests possible involvement in codon recognition and
interactions with aminoacyl-tRNA synthetases.[38] A mechanistic link between stress-induced tRNA reprogramming and
cell stress response is illustrated by oxidation-induced increases
in the level of m5C (Figure 3).
Among other positions in several tRNAs, m5C is located
at the wobble position of tRNALeu(CAA) that reads the UUG
in mRNA, and it confers resistance to H2O2 by
regulating translation of critical stress response proteins from TTG-enriched
genes.[8] So, it is not surprising that m5C appears in the basis set of 14 ribonucleosides in the model.
Similar arguments can be made for other ribonucleosides in the basis
set (Table 1), several of which are located
in a single species of tRNA (mcm5U, mcm5s2U, m3C, Am, yW, m1I). For example, alkylating
agent-induced increases in the relative levels of mcm5U
and mcm5s2U (Figure 3), which are part of the 14 ribonucleoside basis set for the exposure
model, are consistent with our observation that modification of the
wobble position of tRNAArg(UCU) with mcm5U confers
resistance to MMS by promoting the translation of proteins from genes
enriched with the cognate AGA codon, which represent a specific group
of DNA damage-response genes.[6] So, again,
it is not surprising to see elevations of mcm5U and mcm5s2U in MMS-exposed cells. While changes in the
number of copies of specific tRNAs could contribute to the stress-induced
changes in levels of tRNA modifications, along with increased modifying
enzyme activity, our previous tRNA-seq analysis revealed that H2O2 and MMS induced nearly identical patterns of
up- and downregulation for 58 tRNAs, with 18 tRNAs showing opposing
changes for the stresses.[39]Analogous
arguments may provide insights into the role of other stress-regulated
ribonucleosides in Table 1. For example, yW
and m1I are Trm5-dependent modifications that are downregulated
by exposure to the alkylating agents (Figure 3), with yW located at position 37 of tRNAPhe(GAA) and
m1I located at the wobble position 34 of tRNAAla(IGC), respectively. Niu and co-workers have shown that trm5 is an essential gene involved in cell cycle regulation,[40] which raises the possibility that yW and m1I play a role in regulating the translation of cell cycle
proteins during the alkylation stress response. Further evidence for
mechanistic linkage between stress-regulated tRNA modifications and
the stress response arises in the observation of subclass signatures
for both oxidizing (Am changes with ONOO– exposure)
and alkylating agents (m3C changes with SN2
alkyllators MMS and EMS), as discussed next.
tRNA Modification Patterns
Distinguish Different Oxidizing Agents
While the behavior
is more striking for the alkylating agents,
the four oxidizing agents each showed unique patterns of change in
the 23 tRNA modifications (Figure 3 and Table S2). For example, ONOO– uniquely and significantly caused an increase in Am, whereas no
significant change in this ribonucleoside was observed with the other
three oxidizing agent samples (Table S2). The basis for this behavior may lie in the different chemistries
of reactive oxygen species (ROS) and reactive nitrogen species (RNS)
in terms of molecular damage.[41,42] Am is found only at
position 4 of tRNAHis(GUG) in S. cerevisiae.[10,43] Analysis of the yeast genome using the Codon
Counting Database[44] reveals that the cognate
codon for this tRNA, CAC, is found to be significantly enriched in
410 genes in the yeast genome (hypergeometric distribution, p value < 0.01; Table S4).
Of these CAC-enriched genes, yeast flavohemoglobin is a nitric oxide
oxidoreductase, which directly interacts with ONOO– and is involved in NO detoxification. It is well-known to play a
role in the oxidative and nitrosative stress responses.[45]Interestingly, among spectra of the other
three oxidizing agents, H2O2 exposure is more
similar to γ-rad than to another peroxide, TBHP. This may be
due to the fact that H2O2 and γ-rad generate
hydroxyl radicals that lead to chemically distinct types of molecular
damage than the peroxyl radicals arising from TBHP. Thus, there is
likely to be a discrete biological mechanism underlying the tRNA modification
patterns for different chemical stresses, with the subclass signatures
for SN1 and SN2 alkylating agents providing
a striking illustration of the phenomenon.
Correlations between Subclass
Signatures and Mechanisms of Action
among Alkylating Agents
The hierarchical clustering analysis
in Figure 3 reveals a significant differential
alteration of modified ribonucleosides by the two chemically distinct
types of alkylating agents. MMS and EMS represent one class of alkylating
agent that appears to react with nucleophilic sites in nucleic acids,
proteins, and other cellular molecules[46,47] by a bimolecular
nucleophilic substitution reaction (SN2), whereas IMS,
MNNG and NMU appear to react by a unimolecular mechanism (SN1).[48] The relevance of this mechanistic
classification for genetic toxicology has been challenged[49] but the two groups of alkylating agents produce
distinctly different types of molecular damage,[48] and we use the SN1/SN2 nomenclature
for the sake of clarity. The analyses in Figure 3 and Table S2 clearly and significantly
distinguish MMS and EMS from the other three agents in terms of tRNA
modification spectra. For example, the relative levels of m7G and m3C in MMS- and EMS-exposed cells increased more
significantly than in IMS-, MNNG-, and NMU-exposed cells. In contrast,
the levels of Am and Um did not change in response to MMS and EMS,
but they were elevated when cells were treated with the other three
alkylating agents. These results suggest that the cells are responding
to the damage caused by two classes of alkylating agents with different
translational responses that reflect activation of different cellular
survival pathways. This point was demonstrated in 1983 by Smith and
Grisham[50] in studies of cytotoxicity in
yeast. They observed that the toxicity of SN2 alkylating
agents, such as MMS, arises mainly by damage to membrane proteins,
whereas the toxicity of SN1 alkylating agents, such as
MNNG, results from interference with DNA replication.[50] Our data provide a mechanistic model for these observations.
The SN2 agents, MMS and EMS, increased the level of m3C, which is known to occur at position 32 of tRNAThr(IGU), tRNASer(UGA), and tRNASer(CGA) and in the
variable stem of a Ser tRNA.[51−53] The link between these tRNAs
and the proposed membrane protein target of SN2 agents
may lie in the fact that Thr and Ser are significantly enriched in
membrane proteins in eukaryotes.[54−56] Analysis of the S. cerevisiae genome reveals that, on average, 5.9%
of each yeast protein is composed of Thr, whereas only 83 of ∼6000
genes in the yeast genome code for proteins composed of >10% Thr[29] (Tables S4 and S5). Functional analysis of the Thr-enriched proteins by annotation
with Gene Ontology functional attributes using the DAVID bioinformatics
resources[29] revealed that 61 of these 83
genes code for cell wall and cell membrane proteins (Tables S5 and S6). While membrane proteins were not well represented
in our proteomic analysis, which is to be expected given the predominance
of soluble proteins in our isolation method, there was a significant
upregulation of proteins from genes enriched with ThrACT and the optimal codon ThrACC in cells exposed to MMS
(Figure 5). Along with the observation that
loss of the ability synthesize m3C confers sensitivity
to EMS and MMS in Δtrm140 cells (Figure S2), these results are consistent with
the idea that the EMS- and MMS-induced increase in m3C
reflects the need for more efficient translation of Thr-enriched membrane
proteins in the response of S. cerevisiae to exposure to the SN2 alkylating agents. There are certainly
factors other than reprogramming of m3C-cointaining tRNAs
and selective translation of ACT- and ACC-enriched genes in the translational
control of the MMS stress response, as suggested by the downregulation
of some proteins from ACT- and ACC-enriched genes (Figure 5), such as contributions from tRNA modifications
and biased codon usage, as well as factors regulating tRNA charging,
ribosome loading, and translational elongation rates.
Conclusions
We employed novel bioanalytical and computational tools to demonstrate
that cells respond to exposure to different classes of chemical stressors
by reprogramming a system of modified ribonucleosides in tRNA, with
unique patterns distinguishing the class of chemicals, as well as
the subclass. Multivariate statistical analysis and data-driven modeling
of the tRNA modification patterns proved to be highly predictive of
toxicant chemistry, with bioinformatic and proteomic analyses establishing
a mechanistic link among exposure, tRNA modifications, and codon-biased
translation of response proteins. With implications for other organisms,
including humans, these results establish tRNA modifications as predictive
biomarkers of exposure and illustrate a novel regulatory mechanism
for translational control of cell stress response.
Authors: Albrecht Gruhler; Jesper V Olsen; Shabaz Mohammed; Peter Mortensen; Nils J Faergeman; Matthias Mann; Ole N Jensen Journal: Mol Cell Proteomics Date: 2005-01-22 Impact factor: 5.911
Authors: Selina S Dwight; Rama Balakrishnan; Karen R Christie; Maria C Costanzo; Kara Dolinski; Stacia R Engel; Becket Feierbach; Dianna G Fisk; Jodi Hirschman; Eurie L Hong; Laurie Issel-Tarver; Robert S Nash; Anand Sethuraman; Barry Starr; Chandra L Theesfeld; Rey Andrada; Gail Binkley; Qing Dong; Christopher Lane; Mark Schroeder; Shuai Weng; David Botstein; J Michael Cherry Journal: Brief Bioinform Date: 2004-03 Impact factor: 11.622
Authors: Stanislaw Dunin-Horkawicz; Anna Czerwoniec; Michal J Gajda; Marcin Feder; Henri Grosjean; Janusz M Bujnicki Journal: Nucleic Acids Res Date: 2006-01-01 Impact factor: 16.971
Authors: Ivan Rusyn; Rebecca C Fry; Thomas J Begley; Joanna Klapacz; J Peter Svensson; Mark Ambrose; Leona D Samson Journal: PLoS One Date: 2007-11-28 Impact factor: 3.240
Authors: Dalia H Ghoneim; Xiaoju Zhang; Christina E Brule; David H Mathews; Elizabeth J Grayhack Journal: Nucleic Acids Res Date: 2019-02-20 Impact factor: 16.971
Authors: Julie Lorent; Eric P Kusnadi; Vincent van Hoef; Richard J Rebello; Matthew Leibovitch; Johannes Ristau; Shan Chen; Mitchell G Lawrence; Krzysztof J Szkop; Baila Samreen; Preetika Balanathan; Francesca Rapino; Pierre Close; Patricia Bukczynska; Karin Scharmann; Itsuhiro Takizawa; Gail P Risbridger; Luke A Selth; Sebastian A Leidel; Qishan Lin; Ivan Topisirovic; Ola Larsson; Luc Furic Journal: EMBO J Date: 2019-09-26 Impact factor: 11.598
Authors: Frank Doyle; Andrea Leonardi; Lauren Endres; Scott A Tenenbaum; Peter C Dedon; Thomas J Begley Journal: Methods Date: 2016-05-28 Impact factor: 3.608
Authors: Luang Xu; Xinyu Liu; Na Sheng; Kyaw Soe Oo; Junxin Liang; Yok Hian Chionh; Juan Xu; Fuzhou Ye; Yong-Gui Gao; Peter C Dedon; Xin-Yuan Fu Journal: J Biol Chem Date: 2017-06-27 Impact factor: 5.157